Malaria Clinical Trial
Official title:
Can Mass Media Campaigns Reduce Child Mortality
A cluster-randomised trial will be undertaken in Burkina Faso to investigate whether a
comprehensive mass media campaign using local radio stations can change behaviours on a
scale large enough to result in measurable and sustainable reductions in under-five child
mortality.
It is hypothesised that as a result of the scale and multi-pronged nature of the campaign,
reductions of between 10% and 20% in child mortality will be achieved.
Status | Completed |
Enrollment | 100000 |
Est. completion date | April 2015 |
Est. primary completion date | April 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A to 5 Years |
Eligibility |
Inclusion Criteria: - Residence in study clusters Exclusion Criteria: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
Burkina Faso | Centre Muraz | Bobo-Dioulasso |
Lead Sponsor | Collaborator |
---|---|
London School of Hygiene and Tropical Medicine | Centre Muraz, Development Media International, Planet Wheeler Foundation, Wellcome Trust |
Burkina Faso,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Post neonatal under-five all cause mortality | 1 year | No | |
Secondary | Under-5 child all cause mortality | 1year | No | |
Secondary | Preventive behaviours for main causes of under-five children mortality | Antenatal consultations during the last pregnancy which lasts more than 6 months and place of delivery Breastfeeding practices for the youngest under-five child Behaviours to prevent cases of diarrhoea and malaria in the youngest under-five child |
1 year | No |
Secondary | Knowledge | Knowledge about danger signs during pregnancy, delivery and in young ill children Knowledge about preventive measure against malaria during pregnancy Knowledge about recommended breastfeeding behaviours Knowledge about transmission of malaria and diarrhoea Knowledge about health care seeking behaviours in young children suffering from diarrhoea, bad cough |
30-36 months after the start of the intervention | No |
Secondary | Cost-effectiveness of mass media campaigns in terms of dollars per disability-adjusted life year (DALY) averted | 1 year | No | |
Secondary | Curative behaviours for main causes of under-five children mortality | Health care behaviours to treat cases of diarrhoea, fever, cough and respiratory difficulties in the youngest under-five child during the 15 previous days | 15 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
Completed |
NCT02536222 -
Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts
|
Phase 4 |